Document Detail

Development and validation of the Consumer Quality index instrument to measure the experience and priority of chronic dialysis patients.
MedLine Citation:
PMID:  22362785     Owner:  NLM     Status:  Publisher    
BACKGROUND: Patient experience is an established indicator of quality of care. Validated tools that measure both experiences and priorities are lacking for chronic dialysis care, hampering identification of negative experiences that patients actually rate important.METHODS: We developed two Consumer Quality (CQ) index questionnaires, one for in-centre haemodialysis (CHD) and the other for peritoneal dialysis and home haemodialysis (PHHD) care. The instruments were validated using exploratory factor analyses, reliability analysis of identified scales and assessing the association between reliable scales and global ratings. We investigated opportunities for improvement by combining suboptimal experience with patient priority.RESULTS: Sixteen dialysis centres participated in our study. The pilot CQ index for CHD care consisted of 71 questions. Based on data of 592 respondents, we identified 42 core experience items in 10 scales with Cronbach's α ranging from 0.38 to 0.88; five were reliable (α ≥ 0.70). The instrument identified information on centres' fire procedures as the aspect of care exhibiting the biggest opportunity for improvement. The pilot CQ index PHHD comprised 56 questions. The response of 248 patients yielded 31 core experience items in nine scales with Cronbach's α ranging between 0.53 and 0.85; six were reliable. Information on kidney transplantation during pre-dialysis showed most room for improvement. However, for both types of care, opportunities for improvement were mostly limited.CONCLUSIONS: The CQ index reliably and validly captures dialysis patient experience. Overall, most care aspects showed limited room for improvement, mainly because patients participating in our study rated their experience to be optimal. To evaluate items with high priority, but with which relatively few patients have experience, more qualitative instruments should be considered.
Sabine N van der Veer; Kitty J Jager; Ella Visserman; Robert J Beekman; Els W Boeschoten; Nicolette F de Keizer; Lara Heuveling; Karien Stronks; Onyebuchi A Arah
Related Documents :
16907655 - Statins and myotoxicity: a therapeutic limitation.
10559595 - Double-lined frontoparietal scleroderma en coup de sabre.
22642305 - The natural history of motor neuron disease: assessing the impact of specialist care.
22366965 - The global landscape of cross-border reproductive care: twenty key findings for the new...
17823815 - Outcome of paediatric intensive care survivors.
17541455 - Creating a global initiative.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-23
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  -     ISSN:  1460-2385     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.
Next Document:  Disease severity score could not predict the outcomes in peritoneal dialysis-associated peritonitis.